Drug giant Pfizer (PFE - Get Report) is busy selling its nutrition division and spinning off its animal health business. And with all that going on, the stock still remains cheap, says Mark Finn portfolio manager for the T. Rowe Price Value Fund ( TRVLX ).
Pfizer, Dell Top the List
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.